LCM
GSK icon

Lazari Capital Management’s GSK GSK Stock Holding History

Lazari Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Sell
12,240
-904
-7% -$47.8K 0.2% 86
2026
Q1 		$725K Buy
13,144
+143
+1% +$7.75K 0.25% 72
2025
Q4 		$638K Sell
13,001
-900
-6% -$42K 0.21% 75
2025
Q3 		$600K Sell
13,901
-4,120
-23% -$161K 0.2% 78
2025
Q2 		$692K Sell
18,021
-89
-0.5% -$3.4K 0.26% 61
2025
Q1 		$702K Sell
18,110
-1,302
-7% -$47.7K 0.29% 56
2024
Q4 		$657K Sell
19,412
-134
-0.7% -$4.82K 0.26% 62
2024
Q3 		$799K Sell
19,546
-424
-2% -$17.3K 0.34% 51
2024
Q2 		$769K Buy
19,970
+486
+2% +$20.4K 0.35% 51
2024
Q1 		$835K Sell
19,484
-720
-4% -$29.7K 0.45% 37
2023
Q4 		$749K Sell
20,204
-11,600
-36% -$416K 0.43% 38
2023
Q3 		$1.15M Sell
31,804
-60
-0.2% -$2.13K 0.69% 28
2023
Q2 		$1.14M Buy
+31,864
New +$1.14M 0.64% 30

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Lazari Capital Management's GSK Position: Q2 2026 in Review

Lazari Capital Management reduced its GSK (GSK) stake by 6.9% in Q2 2026, selling an estimated $47.8K and leaving 12,240 shares worth $642K. The position accounts for 0.2% of the portfolio, ranked #86.

Lazari Capital Management first reported a position in GSK in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.15M in Q3 2023. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Lazari Capital Management held 12,240 shares of GSK worth $642K as of Q2 2026.
  • Lazari Capital Management sold 904 GSK shares in Q2 2026, an estimated $47.8K.
  • GSK made up 0.2% of Lazari Capital Management's portfolio in Q2 2026, its #86 holding.
  • Lazari Capital Management first reported a position in GSK in Q2 2023 and has held it in 13 quarters since.
  • Lazari Capital Management's GSK position peaked at $1.15M in Q3 2023.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.